The BET-bromodomain inhibitor JQ1 renders neuroblastoma cells more resistant to NK cell-mediated recognition and killing by downregulating ligands for NKG2D and DNAM-1 receptors

Irene Veneziani, Doriana Fruci, Mirco Compagnone, Vito Pistoia, Paolo Rossi, Loredana Cifaldi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The BET-bromodomain inhibitor JQ1 renders neuroblastoma cells more resistant to NK cell-mediated recognition and killing by downregulating ligands for NKG2D and DNAM-1 receptors'. Together they form a unique fingerprint.

Medicine & Life Sciences